Inspire Veterinary Partners, Inc. Class A (IVP) AI Stock Analysis

• Market Cap: $7.40M
• Dividend Yield: N/A
• Average Volume (3M): 63.48K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.94
• Revenue Growth: -10.59%
• EPS Growth: 99.33%
• Country: US
• Employees: 113
• Sector: Consumer Cyclical
• Sector Strength: 61
• Industry: Personal Products & Services
• EPS (TTM): -0.43
• Shares Outstanding: 2,119,551
• 10 Day Avg. Volume: 32,302
• 30 Day Avg. Volume: 63,483
• PEG Ratio: -0.65
• Price to Book (P/B): -166.97
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -302.45
• Enterprise Value/Market Cap: 118.97
• Enterprise Value/Revenue: 13.31
• Enterprise Value/Gross Profit: 303.59
• Enterprise Value/Ebitda: -21.34
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 41 Neutral
• Price Target: $1.50 ▲(4.17%Upside)

The overall stock score is heavily impacted by financial performance issues, including high leverage and negative income. Technical analysis also indicates weak momentum. Despite a positive corporate acquisition, the lack of profitability and valuation concerns result in a low overall score.

Inspire Veterinary Partners, Inc. Class A Business Overview & Revenue Model

Company Description

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals in the United States. The company specializes in small animal general practice hospitals, which serve companion pets, canine, and feline breeds. Its hospitals provide preventive care for companion animals consisting of annual health exams and parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; and skin and coat health, and other breed specific preventive care services. The company also provides surgical services, which include soft tissue procedures, such as spays and neuters, mass removals, splenectomies, gastropexies, orthopedic procedures, and other surgical offerings; and care and alternative procedures, such as acupuncture, chiropractic, and other health and wellness services. Inspire Veterinary Partners, Inc. was incorporated in 2020 and is based in Virginia Beach, Virginia.

How the Company Makes Money

Inspire Veterinary Partners, Inc. makes money primarily through the provision of veterinary services at its network of clinics. Revenue is generated from fees charged for medical consultations, diagnostic tests, surgical procedures, and preventive care services such as vaccinations and wellness exams. Additionally, the company may earn income through the sale of pet-related products, including prescription medications, pet food, and wellness products. Significant partnerships with pet insurance providers and pet product manufacturers could also contribute to its earnings by facilitating access to a broader customer base or offering exclusive services and products.

Inspire Veterinary Partners, Inc. Class A Financial Statement Overview

Summary

Inspire Veterinary Partners, Inc. is facing significant financial challenges with consistent net losses, high leverage, and negative free cash flow. These factors indicate potential risks in terms of liquidity and financial stability, requiring strategic actions to improve profitability and cash flow management.

Income Statement

Inspire Veterinary Partners, Inc. has seen fluctuating revenues with a recent decline in total revenue during TTM. Gross profit margins have been weak, and the company continues to operate at a net loss, indicating challenges in achieving profitability. The negative EBIT and EBITDA margins further highlight ongoing operational inefficiencies and cost management issues.

Balance Sheet

The company has a high debt-to-equity ratio, reflecting significant leverage which poses financial risk. Stockholders’ equity remains low, resulting in a low equity ratio. Negative equity in previous years indicates potential financial instability, although there has been some improvement as of the latest TTM data.

Cash Flow

Inspire Veterinary Partners, Inc. has experienced negative free cash flow, indicating challenges in generating sufficient cash from operations to cover capital expenditures. The operating cash flow to net income ratio is unfavorable due to consistent net losses, reflecting ongoing cash flow struggles.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	15.40M	16.59M	16.68M	9.83M	2.55M	0.00
Gross Profit	2.90M	6.86M	3.55M	2.55M	829.29K	0.00
EBITDA	-8.69M	-9.50M	-10.84M	-2.91M	-977.46K	0.00
Net Income	-13.26M	-14.26M	-14.79M	-4.91M	-1.33M	-5.52K
Balance Sheet
Total Assets	20.66M	20.20M	21.79M	20.19M	6.33M	21.97K
Cash, Cash Equivalents and Short-Term Investments	1.74M	523.69K	178.96K	444.25K	2.06M	21.97K
Total Debt	15.24M	16.37M	18.42M	23.61M	6.69M	0.00
Total Liabilities	17.66M	18.63M	22.58M	25.32M	7.20M	0.00
Stockholders Equity	3.00M	1.56M	-788.26K	-5.14M	-869.09K	21.97K
Cash Flow
Free Cash Flow	-8.31M	-10.24M	-4.20M	-2.84M	-2.32M	-5.52K
Operating Cash Flow	-8.21M	-10.01M	-3.82M	-2.66M	-1.01M	-5.52K
Investing Cash Flow	-101.31K	-238.00K	-1.87M	-14.67M	-4.02M	0.00
Financing Cash Flow	9.90M	10.59M	5.63M	15.71M	7.07M	269.16K

Inspire Veterinary Partners, Inc. Class A Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.44
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IVP, the sentiment is Negative. The current price of 1.44 is below the 20-day moving average (MA) of 1.67, below the 50-day MA of 1.61, and below the 200-day MA of 4.15, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 39.96 is Neutral, neither overbought nor oversold. The STOCH value of 6.40 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IVP.

Inspire Veterinary Partners, Inc. Class A Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JXG	63 Neutral	$6.55M	0.76	17.05%	―	56.53%	10.88%
Sector *	62 Neutral	$16.90B	11.24	-7.48%	2.95%	1.60%	-23.76%
JWEL	52 Neutral	$5.86M	―	-37.82%	―	-16.89%	31.24%
VEEE	46 Neutral	$4.92M	―	-54.97%	―	-57.48%	-27.43%
VMAR	44 Neutral	$7.60M	―	-80.86%	―	-55.43%	55.17%
CTNT	44 Neutral	$4.31M	―	-28.60%	―	―	―
IVP	41 Neutral	$7.40M	―	-809.91%	―	-10.59%	99.33%

Inspire Veterinary Partners, Inc. Class A Corporate Events

Inspire Veterinary Partners Acquires Debary Animal Clinic

On June 5, 2025, Inspire Veterinary Partners, Inc. completed the acquisition of Debary Animal Clinic and its related real estate assets in Florida, marking its fifth acquisition in the state. This acquisition is expected to add approximately $1.8 million in annual revenue and increase the company’s network of animal hospitals to 14, enhancing its presence in the Florida pet care market.

Inspire Veterinary Partners Issues Discount Notes for Capital

On May 30, 2025, Inspire Veterinary Partners, Inc. issued Original Issue Discount Notes to 1800 Diagonal Lending LLC and Boot Capital LLC, with principal amounts of $204,700 and $92,000 respectively, to be used for general working capital. These notes, which mature on March 30, 2026, include provisions for interest payments and allow the lenders to convert the debt into shares of the company’s common stock under certain conditions, impacting the company’s financial strategy and stakeholder interests.

Inspire Veterinary Partners Secures CEO Employment Agreement

Inspire Veterinary Partners, Inc. has formalized an employment agreement with its current CEO, Kimball Carr, for an initial two-year term. The agreement outlines Mr. Carr’s responsibilities, compensation, and conditions for termination, aiming to ensure his full commitment to the company’s interests. The contract includes a base salary, performance bonuses, potential stock awards, and non-disclosure provisions, while also detailing circumstances under which either party may terminate the agreement.